American Journal of Ophthalmology
Volume 138, Issue 6 , Pages 925-930 , December 2004

Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab

  • James A. Garrity, MD

      Affiliations

    • Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA
    • Corresponding Author InformationInquiries to James A. Garrity, MD, Department of Ophthalmology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; fax: 507-284-4612;
    • ,
  • Austin W. Coleman, DO

      Affiliations

    • Departments of Ophthalmology and Neurology, Michigan State University, East Lansing, Michigan USA
    • ,
  • Eric L. Matteson, MD, MPH

      Affiliations

    • Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA
    • ,
  • Eric R. Eggenberger, DO

      Affiliations

    • Departments of Ophthalmology and Neurology, Michigan State University, East Lansing, Michigan USA
    • ,
  • David M. Waitzman, MD

      Affiliations

    • University of Connecticut Health Center, Farmington, ConnecticutUSA.

,Accepted 22 June 2004.

References 

  1. Kennerdell JS , Dresner SC . The nonspecific orbital inflammatory syndromes . Surv Ophthalmol . 1984;29:93–103
  2. McNicholas MM , Power WJ , Griffin JF . Idiopathic inflammatory pseudotumour of the orbit (CT features correlated with clinical outcome) . Clin Radiol . 1991;44:3–7
  3. Mombaerts I , Goldschmeding R , Schlingemann RO , Koornneef L . What is orbital pseudotumor? . Surv Ophthalmol . 1996;41:66–78
  4. Nugent RA , Rootman J , Robertson WD , Lapointe JS , Harrison PB . Acute orbital pseudotumors (classification and CT features) . AJR Am J Roentgenol . 1981;137:957–962
  5. Rootman J , McCarthy M , White V , Harris G , Kennerdell J . Idiopathic sclerosing inflammation of the orbit (a distinct clinicopathologic entity) . Ophthalmology . 1994;101:570–584
  6. Weissler MC , Miller E , Fortune MA . Sclerosing orbital pseudotumor (a unique clinicopathologic entity) . Ann Otol Rhinol Laryngol . 1989;98:496–501
  7. Mombaerts I , Schlingemann RO , Goldschmeding R , Koornneef L . Are systemic corticosteroids useful in the management of orbital pseudotumors? . Ophthalmology . 1996;103:521–528
  8. Mombaerts I , Koornneef L . Current status in the treatment of orbital myositis . Ophthalmology . 1997;104:402–408
  9. Zurlo A , Sancesario G , Bernardi G , Loasses A . Orbital pseudotumor (case report and literature review) . Tumori . 1999;85:68–70
  10. Smitt MC , Donaldson SS . Radiation therapy for benign disease of the orbit . Semin Radiat Oncol . 1999;9:179–189
  11. Criscione LG , St Clair EW . Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases . Curr Opin Rheumatol . 2002;14:204–211
  12. Ricart E , Panaccione R , Loftus EV , Tremaine WJ , Sandborn WJ . Infliximab for Crohn’s disease in clinical practice at the Mayo Clinic (the first 100 patients) . Am J Gastroenterol . 2001;96:722–729
  13. Taylor PC . Anti-tumor necrosis factor therapies . Curr Opin Rheumatol . 2001;13:164–169
  14. Rutgeerts P , D’Haens G , Targan S , Vasiliauskas E , Hanauer SB , Present DH , et al.   Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease . Gastroenterology . 1999;117:761–769
  15. Olsen NJ , Stein CM . New drugs for rheumatoid arthritis . N Engl J Med . 2004;350:2167–2179
  16. Bullen CL , Younge BR . Chronic orbital myositis . Arch Ophthalmol . 1982;100:1749–1751
  17. Ludwig I , Tomsak RL . Acute recurrent orbital myositis . J Clin Neuroophthalmol . 1983;3:41–47
  18. Mannor GE , Rose GE , Moseley IF , Wright JE . Outcome of orbital myositis (clinical features associated with recurrence) . Ophthalmology . 1997;104:409–413
  19. Weinstein GS , Dresner SC , Slamovits TL , Kennerdell JS . Acute and subacute orbital myositis . Am J Ophthalmol . 1983;96:209–217
  20. Divine RD , Anderson RL . Metastatic small cell carcinoma masquerading as orbital myositis . Ophthalmic Surg . 1982;13:483–487
  21. Dooley DP , Hollsten DA , Grimes SR , Moss J . Indolent orbital apex syndrome caused by occult mucormycosis . J Clin Neuroophthalmol . 1992;12:245–249
  22. Harris GJ , Murphy ML , Schmidt EW , Hanson GA , Dotson RM . Orbital myositis as a paraneoplastic syndrome . Arch Ophthalmol . 1994;112:380–386
  23. Hutnik CM , Nicolle DA , Munoz DG . Orbital aspergillosis (a fatal masquerader) . J Neuroophthalmol . 1997;17:257–261
  24. Spoor TC , Hartel WC , Harding S , Kocher G . Aspergillosis presenting as a corticosteroid-responsive optic neuropathy . J Clin Neuroophthalmol . 1982;2:103–107
  25. Thorne JE , Volpe NJ , Wulc AE , Galetta SL . Caught by a masquerade (sclerosing orbital inflammation) . Surv Ophthalmol . 2002;47:50–54
  26. Tokayer A , Carsons SE , Chokshi B , Santiago-Schwarz F . High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy (association with dendritic cell growth activity) . J Rheumatol . 2002;29:454–461
  27. Kremer JM . Rational use of new and existing disease-modifying agents in rheumatoid arthritis . Ann Intern Med . 2001;134:695–706
  28. Antoni C , Braun J . Side effects of anti-TNF therapy (current knowledge) . Clin Exp Rheumatol . 2002;20(Suppl 28):S152–S157
  29. Foroozan R , Buono LM , Sergott RC , Savino PJ . Retrobulbar optic neuritis associated with infliximab . [published erratum appears in Arch Ophthalmol 2002;120:1188] Arch Ophthalmol . 2002;120:985–987
  30. Sicotte NL , Voskuhl RR . Onset of multiple sclerosis associated with anti-TNF therapy . Neurology . 2001;57:1885–1888
  31. ten Tusscher MP , Jacobs PJ , Busch MJ , de Graaf L , Diemont WL . Bilateral anterior toxic optic neuropathy and the use of infliximab . BMJ . 2003;326:579
  32. Lock C , Oksenberg J , Steinman L . The role of TNFα and lymphotoxin in demyelinating disease . Ann Rheum Dis . 1999;58(Suppl 1):1121–1128
  33. Mohan N , Edwards ET , Cupps TR , Oliverio PJ , Sandberg G , Crayton H , et al.   Demyelination occurring during anti-tumor necrosis factor α therapy for inflammatory arthritides . Arthritis Rheum . 2001;44:2862–2869
  34. Aithal GP , Mansfield JC . Review article (the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment) . Am J Ophthalmol . 2001;15:1101–1108
  35. Bickston SJ , Lichtenstein GR , Arseneau KO , Cohen RB , Cominelli F . The relationship between infliximab treatment and lymphoma in Crohn’s disease . Gastroenterology . 1999;117:1433–1437
  36. Brown SL , Greene MH , Gershon SK , Edwards ET , Braun MM . Tumor necrosis factor antagonist therapy and lymphoma development (twenty-six cases reported to the Food and Drug Administration) . Arthritis Rheum . 2002;46:3151–3158

PII: S0002-9394(04)00827-X

doi: 10.1016/j.ajo.2004.06.077

American Journal of Ophthalmology
Volume 138, Issue 6 , Pages 925-930 , December 2004

Article Tools